Avoiding Reporting Delays in Expedited SAE Submissions: Best Practices
Avoiding Reporting Delays in Expedited SAE Submissions: Best Practices Best Practices to Avoid Reporting Delays in Expedited SAE Submissions Why Delays in Expedited Reporting Are a Critical Risk Timely reporting of Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) is one of the most critical regulatory obligations in clinical trials. Agencies such…
Read More “Avoiding Reporting Delays in Expedited SAE Submissions: Best Practices” »